Evidence-Based Complementary and Alternative Medicine

Effects and Molecular Mechanisms of Non-Drug Therapy on Neural Plasticity and Repair after Stroke


Publishing date
01 Dec 2022
Status
Closed
Submission deadline
12 Aug 2022

Lead Editor

1Yunnan University of Chinese Medicine, Kunming, China

2Fudan University, Shanghai, China

3The University of Tennessee Health Science Center, Memphis, USA

4Second Hospital of Hebei Medical University, Shijiazhuang, China

This issue is now closed for submissions.

Effects and Molecular Mechanisms of Non-Drug Therapy on Neural Plasticity and Repair after Stroke

This issue is now closed for submissions.

Description

Stroke is the primary cause of death and long-term disability worldwide, and most survivors of cerebral ischemia experience a combination of motor, cognitive, learning, memory, and language deficits. Despite some drugs and neurotrophic agents having been proved to be effective in animal studies, serious side effects and unsatisfactory clinical efficacy have limited the clinical application of these drugs. Therefore, there is an urgent need to explore novel effective non-drug therapies for improving neural repair and functional recovery after stroke.

Non-drug therapies are medical therapies that include neuroregulatory techniques, such as transcranial magnetic stimulation (TMS), transcranial electrical stimulation (TES), or motor imagery therapy), and traditional Chinese treatments like acupuncture or Tai Chi. However, high-quality evidence-based clinical research is scarce and the molecular mechanisms of non-drug therapy in the treatment of stroke remain poorly understood. The technical standards and regulations of non-drug therapy need to be clarified to maximize outcomes, including indications and contraindications, parameters, and time windows. Fortunately, more and more researchers are now investigating the effects of non-drug therapy, and there is increasing amounts of research into the effects and molecular mechanisms of non-drug therapy on neural plasticity and neural repair after stroke.

The aim of this Special Issue is to increase our knowledge of how non-drug therapy improves neural plasticity and reconstruction of functions, and to probe into the undergoing mechanisms of non-drug therapy after stroke. We welcome clinical studies and animal studies about the application of novel non-drug therapy, techniques, and devices of rehabilitation, and the mechanisms of non-drug therapy. We welcome both original research and review articles.

Potential topics include but are not limited to the following:

  • Effects and molecular mechanisms of transcranial magnetic stimulation
  • Effects and molecular mechanisms of transcranial electrical stimulation
  • Effects and molecular mechanisms of transcranial acupuncture and electrical acupuncture
  • The effects and molecular mechanisms of traditional Chinese medicine exercises, such as Tai Chi and Yi Jin Jing
  • The effects and molecular mechanisms of electrical stimulation in peripheral nerves or median nerves
  • The effects and molecular mechanisms of treatment strategies with multi-technology combinations
  • The effects and molecular mechanisms of intelligent rehabilitation devices
  • The molecular mechanisms of physical therapy

Articles

  • Special Issue
  • - Volume 2023
  • - Article ID 9864202
  • - Retraction

Retracted: Mechanism of LncHOTAIR Regulating Proliferation, Apoptosis, and Autophagy of Lymphoma Cells through hsa-miR-6511b-5p/ATG7 Axis

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9876715
  • - Retraction

Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9846548
  • - Retraction

Retracted: Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9853753
  • - Retraction

Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9819124
  • - Retraction

Retracted: MiR-19b-3p Attenuates Chondrocytes Injury by Inhibiting MAPK/NF-Κb Axis via Targeting SOCS1

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9857416
  • - Retraction

Retracted: Multivariate Analysis of Recurrence after Hysteroscopic Diagnosis and Treatment of Endometrial Polyps following IVF-ET Failure

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9813924
  • - Retraction

Retracted: Carbetocin Controls Intraoperative Blood Loss and Thickness of Myometrium in Scar Uterus Cases

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9829428
  • - Retraction

Retracted: LncRNA-PAX8-AS1 Silencing Decreases Cell Viability, Enhances Apoptosis, and Suppresses Doxorubicin Resistance in Myeloid Leukemia via the miR-378g/ERBB2 Axis

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9821568
  • - Retraction

Retracted: Effect of Percutaneous Nephrolithotomy Combined with Needle Nephrolithotomy on Renal Function and Complication Rate in Patients with Complex Renal Calculi

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9856193
  • - Retraction

Retracted: Paeoniflorin Protects H9c2 Cardiomyocytes against Hypoxia/Reoxygenation Induced Injury via Regulating the AMPK/Nrf2 Signaling Pathway

Evidence-Based Complementary and Alternative Medicine
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision145 days
Acceptance to publication29 days
CiteScore3.500
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.